Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» endometrial cancer
endometrial cancer
AstraZeneca Shows Lynparza Combo Could Address Unmet Endometrial Cancer Need
BioSpace
Mon, 03/18/24 - 05:19 pm
AstraZeneca
Lynparza
Imfinzi
endometrial cancer
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data
BioSpace
Mon, 03/18/24 - 05:11 pm
GSK
Jemperli
endometrial cancer
GSK's cancer drug combination meets primary goal in late-stage trial
Reuters
Mon, 12/18/23 - 10:10 am
GSK
Zejula
Jemperli
endometrial cancer
clinical trials
Merck-Eisai's endometrial cancer therapy combo fails first-line treatment trial
Reuters
Fri, 12/8/23 - 09:59 am
Merck
Eisai
4523.T
clinical trials
endometrial cancer
Keytruda
Lenvima
GSK's Jemperli prolongs life in endometrial cancer trial. Will FDA label expansion come next?
Fierce Pharma
Mon, 10/30/23 - 10:12 am
GSK
Jemperli
endometrial cancer
clinical trials
ESMO: AstraZeneca proposes adding Lynparza to Imfinzi as endometrial cancer race heats up
Fierce Pharma
Mon, 10/23/23 - 09:07 am
ESMO
AstraZeneca
Merck
Lynparza
endometrial cancer
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Fierce Pharma
Mon, 07/31/23 - 09:59 pm
GSK
FDA
immunotherapy
endometrial cancer
Jemperli
AstraZeneca reports positive results from endometrial cancer therapy trial
Clinical Trials Arena
Mon, 05/29/23 - 12:24 pm
AstraZeneca
endometrial cancer
clinical trials
Imfinzi
Lynparza
AstraZeneca's drug combo shows positive results in late-stage cancer trial
Reuters
Fri, 05/26/23 - 10:09 am
ASCO 2023
AstraZeneca
Imfinzi
Lynparza
endometrial cancer
Merck Eyes Third Endometrial Cancer Nod for Keytruda
BioSpace
Fri, 02/3/23 - 10:30 am
Merck
Keyruda
clinical trials
endometrial cancer
GSK Notches Phase III Win for Jemperli in Endometrial Cancer
BioSpace
Sun, 12/4/22 - 01:13 pm
GSK
Jemperli
clinical trials
endometrial cancer
A startup plans an IPO to give a shelved Lilly drug another shot
BioPharma Dive
Wed, 10/19/22 - 10:39 am
Acrivon Therapeutics
IPOs
Eli Lilly
prexasertib
ovarian cancer
endometrial cancer
bladder cancer
precision medicine
Could This FDA Approval Be a Boost for Merck?
Motley Fool
Thu, 04/28/22 - 11:04 am
Merck
Keytruda
FDA
endometrial cancer
FDA approves Merck’s anti-PD-1 therapy for endometrial carcinoma patients
Pharmaceutical Business Review
Tue, 03/22/22 - 10:41 am
Merck
Keytruda
endometrial cancer
FDA
Merck, Eisai notch full approval for Keytruda-TKI inhibitor combo in advanced endometrial cancer
Endpoints
Thu, 07/22/21 - 10:14 pm
Merck
Keytruda
Lenvima
endometrial cancer
FDA
FDA approves GSK drug for endometrial cancer with specific genetic signature
MedCity News
Thu, 04/22/21 - 11:30 pm
GSK
Jemperli
dostarlimab
FDA
endometrial cancer
Merck breathes a sigh of relief as Keytruda-Lenvima combo aces confirmatory study in endometrial cancer
Endpoints
Fri, 03/19/21 - 10:51 am
Merck
FDA
Keytruda
Eisai
Lenvima
clinical trials
endometrial cancer
Glaxo joins the Covid-19 delay queue
EP Vantage
Wed, 01/20/21 - 10:50 am
GSK
dostarlimab
COVID-19
FDA
pandemic
endometrial cancer
GSK posts middling data from PD-1 Tesaro buyout drug
Fierce Biotech
Fri, 04/24/20 - 11:00 am
GSK
Tesaro
dostarlimab
clinical trials
endometrial cancer
ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK
Fierce Pharma
Sun, 09/29/19 - 09:37 pm
Merck
Eisai
Keytruda
Lenvima
endometrial cancer
ESMO
Pages
1
2
next ›
last »